Skip to main content
. 2022 Apr 26;12(5):685. doi: 10.3390/jpm12050685

Table 2.

Molecular characteristics of patients.

Parameter Result
EGFRvIII
 positive 184 (51.8%)
 negative 171 (48.2%)
MGMT promoter
 methylated 198 (56.3%)
 unmethylated 154 (43.8%)
VEGF
 hyperexpressed 235 (87%)
 not hyperexpressed 35 (13%)
Proliferation index, median (range) 35% (4–70)